KRAS NRAS Mutation Analysis Panel Test
Comprehensive Genetic Testing for Precision Cancer Care
The KRAS NRAS Mutation Analysis Panel represents a breakthrough in molecular diagnostics for cancer patients, providing critical genetic information that directly impacts treatment decisions and clinical outcomes. This advanced genetic panel specifically targets mutations in the KRAS and NRAS genes, which are among the most frequently mutated oncogenes in human cancers. Understanding these genetic alterations enables oncologists to implement precision medicine approaches that can significantly improve patient survival and quality of life.
What Does the KRAS NRAS Mutation Analysis Panel Measure?
This sophisticated genetic test detects specific mutations in two crucial RAS family genes:
- KRAS Mutations: Identifies mutations in codons 12, 13, and 61 of the KRAS gene, which are commonly associated with resistance to EGFR-targeted therapies
- NRAS Mutations: Detects mutations in the NRAS gene, particularly important in melanoma and colorectal cancer treatment planning
- Comprehensive Analysis: Utilizes PCR, fragment analysis, and sequencing technologies to ensure high sensitivity and specificity
- Clinically Relevant Variants: Focuses on mutations with established clinical significance and treatment implications
Who Should Consider This Genetic Test?
The KRAS NRAS Mutation Analysis Panel is particularly valuable for patients with:
- Colorectal cancer considering anti-EGFR therapy
- Non-small cell lung cancer requiring targeted treatment options
- Pancreatic cancer for prognostic and therapeutic guidance
- Melanoma patients being evaluated for targeted therapies
- Patients with metastatic disease requiring personalized treatment approaches
- Individuals with treatment-resistant cancers needing alternative therapeutic strategies
Key Benefits of KRAS NRAS Mutation Testing
- Personalized Treatment Selection: Guides the choice of targeted therapies based on individual genetic profiles
- Predictive Value: Helps predict response to specific cancer treatments, particularly EGFR inhibitors
- Prognostic Information: Provides valuable insights into disease progression and potential outcomes
- Avoid Unnecessary Treatment: Prevents administration of ineffective therapies that may cause side effects without benefit
- Clinical Trial Eligibility: Identifies patients who may qualify for specific clinical trials based on mutation status
- Comprehensive Cancer Management: Supports multidisciplinary cancer care with precise genetic information
Understanding Your Test Results
Your KRAS NRAS Mutation Analysis Panel results will provide clear, actionable information:
- Mutation Detected: Indicates the presence of specific KRAS or NRAS mutations that may impact treatment decisions
- No Mutation Detected: Suggests potential eligibility for certain targeted therapies, particularly EGFR inhibitors
- Clinical Interpretation: Results include expert interpretation explaining the clinical significance of findings
- Treatment Recommendations: Provides guidance on potential therapeutic implications based on mutation status
- Follow-up Testing: May suggest additional genetic testing if clinically indicated
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| KRAS NRAS Mutation Analysis Panel Test | $376 USD | $626 USD |
Nationwide Testing Availability
GGC DNA provides comprehensive KRAS NRAS Mutation Analysis Panel testing across the United States, with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art molecular diagnostics laboratories ensure accurate, reliable results with a turnaround time of: Sample Tuesday by 11 AM; Report Monday.
Sample Requirements and Testing Process
For optimal testing accuracy, please ensure:
- Submit formalin fixed paraffin embedded tissue block
- Ship at room temperature with proper packaging
- Block should contain at least 10% tumor tissue
- Complete NGS Test Requisition Form (Form 40) is mandatory
- Follow all pre-test instructions provided by your healthcare provider
Take Control of Your Cancer Treatment Journey
Don’t leave your cancer treatment to chance. The KRAS NRAS Mutation Analysis Panel provides the genetic insights needed to make informed treatment decisions. Our expert team at GGC DNA is committed to delivering accurate, timely results that can make a real difference in your cancer care.
Ready to get started? Book your KRAS NRAS Mutation Analysis Panel test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Take the first step toward personalized cancer care with genetic testing that matters.
